- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE release decision-making software
A product released this week by GE Healthcare is designed to give physicians information about clinical data and best treatment practices, where and when they need it.
GE release decision-making software
A product released this week by GE Healthcare is designed to give physicians information about clinical data and best treatment practices, where and when they need it. The computerized decision support solution, developed with Intermountain Healthcare and drawing on its three decades of clinical informatics experience, is intended for use at the point of care. It promises to help improve patient outcomes and efficiency, ultimately helping to reduce costs, according to GE. Intermountain will begin using the software next month in its clinical practices. GE will unveil the full product at the March 2010 meeting of the Healthcare Information Management and Systems Society. The new technology enables real-time clinical review, capturing vital data from electronic medical records and signaling the physician if the proposed actions vary from accepted practice standards.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
